303 Management, Inc. – Trademark Portfolio
Entity Type: 03
303 Management, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 7 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include OLIVEPOP, EXCELSIOR, DINE N' VIEW, MOVIES YOUR WAY, and AMERICA'S MOST LUXURIOUS MOVIE THEATRES. The owner is based in Lake Angelus, MI.
303 Gray Woods Lane
Lake Angelus, MI 48326
Showing of trademarks Trademarks
Trademark Classifications
303 Management, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does 303 Management, Inc. have?
303 Management, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 abandoned.
What trademark classes does 303 Management, Inc. file in?
303 Management, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 30 (Staple Foods). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are 303 Management, Inc.'s most well-known trademarks?
303 Management, Inc.'s registered trademark portfolio includes well-known marks such as OLIVEPOP, EXCELSIOR, DINE N' VIEW, MOVIES YOUR WAY, and AMERICA'S MOST LUXURIOUS MOVIE THEATRES. These are among 5 currently registered trademarks in the portfolio.
What is 303 Management, Inc.'s trademark registration success rate?
303 Management, Inc. has a 63% trademark registration rate, with 5 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.